1275696

Novartis Singapore Pharmaceutical Manufacturing Pte. Ltd. — FEI 3006627732

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
February 20, 2020
Fiscal Year
2020
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Singapore (Singapore)

Additional Details

Mutual Recognition Agreement (MRA)